366 related articles for article (PubMed ID: 33762087)
1. SWI/SNF deficient central nervous system neoplasms.
Cai C
Semin Diagn Pathol; 2021 May; 38(3):167-174. PubMed ID: 33762087
[TBL] [Abstract][Full Text] [Related]
2. SWI/SNF complex-deficient soft tissue neoplasms: An update.
Schaefer IM; Hornick JL
Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
[TBL] [Abstract][Full Text] [Related]
3. Hereditary SWI/SNF complex deficiency syndromes.
Agaimy A; Foulkes WD
Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF-deficient tumors of the central nervous system: An update.
Hasselblatt M; Kool M; Frühwald MC
Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
[TBL] [Abstract][Full Text] [Related]
6. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
7. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
[TBL] [Abstract][Full Text] [Related]
8. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.
Schaefer IM; Agaimy A; Fletcher CD; Hornick JL
Mod Pathol; 2017 Apr; 30(4):539-548. PubMed ID: 28084340
[TBL] [Abstract][Full Text] [Related]
9. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
[TBL] [Abstract][Full Text] [Related]
10. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract][Full Text] [Related]
11. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract][Full Text] [Related]
13. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
[TBL] [Abstract][Full Text] [Related]
14. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Switch/Sucrose Nonfermenting Complex Proteins and Nestin Expression in a Cohort of Pediatric Central Nervous System Tumors.
Wang XQ; Tessier-Cloutier B; Saunders J; Harvey M; Armstrong L; Ng T; Dunham C; Bush JW
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):304-310. PubMed ID: 37036408
[TBL] [Abstract][Full Text] [Related]
16. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF chromatin remodeling complexes and cancer.
Biegel JA; Busse TM; Weissman BE
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
[TBL] [Abstract][Full Text] [Related]
19. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
[TBL] [Abstract][Full Text] [Related]
20. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]